Advertisement

The Clinical Relevance of Disturbances of Uterine Vascular Growth, Remodeling, and Repair

  • Martha Hickey
  • Ian S. Fraser
Part of the Cardiovascular Molecular Morphogenesis book series (CARDMM)

Abstract

Endometrial blood vessels are unique in the manner in which they undergo monthly cycles of dramatic growth, disruption, remodeling, and repair, rivaled only by the remarkable vascular growth and regression occurring during formation and subsequent demise of the ovarian corpus luteum. In the normal menstrual cycle the regular endometrial vascular and tissue disruption and remodeling is associated with frank bleeding known as menstruation. The volume and duration of this bleeding is generally very precisely controlled by a number of fail-safe mechanisms. The overall cyclical changes occurring in endometrium are regulated by a complex sequence of interacting cellular and molecular processes. Any of these processes may be disturbed under certain circumstances.

Keywords

Vascular Endothelial Growth Factor Uterine Fibroid Menstrual Bleeding Human Endometrium Normal Menstrual Cycle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abulafia, O., and Sherer, D. M. 1999. Angiogenesis of the endometrium. Obstet. Gynecol. 94:148–153.PubMedCrossRefGoogle Scholar
  2. Adelentado, J. M., Rees, M. C. P., Lopez Bernal, A., and Turnbull, A. C. 1988. Increased uterine prostaglandin E receptors in menorrhagic women. Br. J. Obstet. Gynaecol. 95:162–165.Google Scholar
  3. Au, C. L., and Rogers, P. A. W. 1993. Immunohistochemical staining of von Willebrand factor in human endometrium during the normal menstrual cycle. Hum. Reprod. 8:17–23. BelseyGoogle Scholar
  4. E. M., and Carlson, N. 1991. The description of menstrual bleeding patterns: towards fewer measures. Stat. Med 10:267–284CrossRefGoogle Scholar
  5. Belsey, E. M., and Pinol, A. P. Y. 1997. Task Force on Long-Acting Systemic Agents for Fertility Regulation. Menstrual bleeding patterns in untreated women. Contraception 55:57–65.PubMedCrossRefGoogle Scholar
  6. Blackwell, P. M., and Fraser, I. S. 1981. Superficial lymphatics in the functional zone of the normal human endometrium. Microvasc. Res. 21:142–152.PubMedCrossRefGoogle Scholar
  7. Brewer, J. I. 1938. Rhythmic changes in skin capillaries and their relation to menstruation. Am. J. Obstet. Gynecol. 36:597–612.Google Scholar
  8. Brosens, J. J., Brosens, I. A. 1998. Adenomyosis uteri. In: Cameron, I. T., Fraser, I. S., and Smith, S. K., eds. Clinical Disorders of the Endometrium and Menstrual Cycle. Oxford University Press, Oxford, pp. 297–312.Google Scholar
  9. Bulletti, C., Jansonni, V. M., Polli, V., Cappucini, F., Galassi, A., Flamingni, C. 1988. Basement membrane components in normal, hyperplastic and neoplastic endometrium. Cancer 63:142–149.CrossRefGoogle Scholar
  10. Bulmer, J. N., Johnson, P. M., and Bulmer, D. 1987. Leukocyte populations in human decidua and endometrium. In: Gill, R. J., and Wegmann, T. J., eds. Immunoregulation and Fetal Survival. Oxford University Press, Oxford, pp. 111–134.Google Scholar
  11. Bulmer, J. N., Lunny, D. R, and Hagin, S. V. 1988. Immunohistochemical characterisation of stromal leukocytes in non-pregnant human endometrium. Am. J. Reprod. Immunol. Microbiol. 17:83–90.PubMedGoogle Scholar
  12. Bulmer, J. N., Jones, R. K., and Searle, R. F. 1998. Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Hum. Reprod. 13:2910–2915.PubMedCrossRefGoogle Scholar
  13. Cameron, I. T. 1989. Dysfunctional uterine bleeding. Baillieres Clin. Obstet. Gynaecol. 3:315–327.PubMedCrossRefGoogle Scholar
  14. Cameron, I. T., Davenport, A. R, Brown, M. J., and Smith S. K. 1991. Endothelin-1 stimulates PGF2a, release from human endometrium. Prostaglandins Leukot. Essent. Fatty Acids 42:155–158.PubMedCrossRefGoogle Scholar
  15. Cameron, I. T., Plumpton, C., Champeney, R., van Papendorp, C., Ashby, M. J., and Davenport, A. P. 1993. Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium. J. Reprod. Fertil. 97:251–255.Google Scholar
  16. Casey, M. L., and MacDonald, R. C. 1996. The endothelin-parathyroid hormone-related protein vasoactive peptide system in human endometrium: modulation by transforming growth factor-beta. In: Findlay, J., and Affandi, B., eds. Menstrual Disorders and Progestin Contraception. Hum. Reprod. 11(suppl 2):62–82.Google Scholar
  17. Casley-Smith, J. R., and Florey, H. W. 1961. The structure of normal small lymphatics. Q. J. Exp. Physiol. 46:101–106.Google Scholar
  18. Casslen, B., and Astedt, B. 1983. Reduced plasminogen activator content of endometrium in oral contraceptive users. Contraception 28:181–188.PubMedCrossRefGoogle Scholar
  19. Charnock-Jones, D. S., Sharkey, A. M., Rajput-Williams, J., Burch, D., Schofield, J. R, Fountain, S. A., Boocock, C. A., and Smith, S. K. 1993. Identification and localisation of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and steroid regulation in endometrial carcinoma cell lines. Biol. Reprod. 48:11201128.Google Scholar
  20. Chiang, C. H., Chang, M. Y., Hsu, J. J., Chiu. T. H., Lee, K. F., Hsieh, T. T., and Soong, Y. K. 1999. Tumor vascular pattern and blood flow impedance in the differential diagnosis of leiomyoma and adenomyosis by color Doppler sonography. J. Assist. Reprod. Genet. 16:268–275.PubMedCrossRefGoogle Scholar
  21. Christiaens, G. C. M. L., Sixma, J. J., and Haspels, A. A. 1982. Haemostasis in menstrual endometrium: a review. Am. J. Reprod. Immunol. 5:78–83.Google Scholar
  22. Clark, D. A., and Daya, S. 1990. Macrophages and other migratory cells in endometrium: relevance to endometrial bleeding. In: d’Arcangues, C., Fraser, I. S., Newton, J. R., and Odlind, V., eds. Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, pp. 363–379.Google Scholar
  23. Clark, D. A., Wang, S., Rogers, R A. W., Vince, G., and Affandi, B. 1996. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant). Hum. Reprod. 11:1438–1444.PubMedCrossRefGoogle Scholar
  24. Clemetson, C. A., Blair, L., and Brown, A. B. 1962. Capillary strength and the menstrual cycle. Ann. NY Acad. Sci. 93:279–299.PubMedCrossRefGoogle Scholar
  25. Corner, G. W. 1942. The Hormones in Human Reproduction. Princeton University Press, Princeton, NJ.Google Scholar
  26. Coulter, A., Noone, A., and Goldacre, M. 1989. General practitioner’s referrals to specialist outpatient clinics. Br. Med. J. 299:304–308.CrossRefGoogle Scholar
  27. Critchley, H. O. D., Bailey, D. A., Au, C. L., Affandi, B., and Rogers, R A. 1993. Immunohistochemical sex steroid receptor distibution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum. Reprod. 8:1632–1639.PubMedGoogle Scholar
  28. Critchley, H. O. D., Abberton, K. M., Taylor, N. H., Healy, D. L., and Rogers, P. A. 1994. Endometrial sex steroid receptor expression in women with menorrhagia. Br. J. Obstet. Gynaecol. 101:428–434. PubMedCrossRefGoogle Scholar
  29. Critchley, H. O. D., Wang, H., Kelly, R. W., Gebbie, A. E., and Glasier, A. F. 1998. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum. Reprod. 13:1210–1217. PubMedCrossRefGoogle Scholar
  30. Das, S. K., Chakraborty, I., Wang, J., Dey, S. K., and Hoffman, L. H. 1997. Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus. Biol. Reprod. 56:1390–1399. PubMedCrossRefGoogle Scholar
  31. Enders, A. C., and Blankenship, T. N. 1997. Modification of endometrial arteries during invasion by cytotrophoblast cells in the pregnant macaque. Acta. Anat. (Basel) 159:169–193. Google Scholar
  32. Farrer-Brown, G., Beilby, J. O. W., and Tarbit, M. H. 1970 The blood supply of the uterus. 1: arterial vasculature. J. Obstet. Gynaecol. Br. Commonw. 77:672–681 Google Scholar
  33. Farrer-Brown, G., Beilby, J. O. W., and Tarbit, M. H. 1971. Venous changes in the endometrium of myomatous uteri. Obstet. Gynecol. 38:743–751. PubMedGoogle Scholar
  34. Ferenczy, A. 1998. Pathophysiology of adenomyosis. Hum. Reprod. Update 4:313–322. Ferenczy, A., Bertrand, G., and Gelfand, M. N. 1979. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J. Obstet. Gynecol. 133:859–867. Google Scholar
  35. Finn, C. A. 1986. Implantation, menstruation and inflammation. Biol. Rev. 61:313–328. PubMedCrossRefGoogle Scholar
  36. Fleming, H., Ostor, A. G., Pickel, H., and Fortune, D. W. 1989. Arteriovenou malforma-tions of the uterus. Obstet. Gynecol. 73:209–213. PubMedGoogle Scholar
  37. Flynn, M. K., and Levine, D. 1996. The noninvasive diagnosis and management of a uterine arteriovenous malformation. Obstet.88:650–652. CrossRefGoogle Scholar
  38. Foley, M. E., Griffin, B. D., and Zugel, M. 1978. Heparin-like activity in uterine fluid. Br. Med. J. 11:322–324. CrossRefGoogle Scholar
  39. Forsling, M. L., Stromberg, P., and Akerlund, M. 1982. Effect of ovarian steroids on vasopressin secretion. J. Endocrinol. 95:147–151. PubMedCrossRefGoogle Scholar
  40. Fraser, I. S. 1985. The dysfunctional uterus: dysmenorrhoea and dysfunctional uterine bleeding. In: Shearman, R. P., ed. Clinical Reproductive Endocrinology. Churchill Livingstone, Edinburgh, pp. 579–598. Google Scholar
  41. Fraser, I. S. 1989. Treatment of menorrhagia. Baillieres Clin. Obstet. Gynaecol. 3:391–402. Google Scholar
  42. Fraser, I. S., Hickey, M., and Song, J. Y. 1996. A comparison of mechanisms underlying dis-turbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum. Reprod. 11(suppl 2):165–178. PubMedCrossRefGoogle Scholar
  43. Fraser, I. S., McCarron, G., Hutton, B. F., and Macey, D. 1987. Endometrial blood flow measured by xenon-133 clearance in women with normal menstrual cycles and dysfunctional uterine bleeding. Am. J. Obstet. Gynecol. 156:158–166. PubMedGoogle Scholar
  44. Fraser, I. S., McCarron, G., Markham, R., and Resta, T. 1985. Blood and total fluid content of menstrual discharge. Obstet. Gynecol. 65:194–198. PubMedGoogle Scholar
  45. Fraser, I. S., McCarron, G., Markham, R., Resta, T., and Watts, A. 1986. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. Obstet. Gynecol. 68:630–633. PubMedGoogle Scholar
  46. Gargett, C. E., Lederman, F. L., Lau, T. M., Taylor, N. H., and Rogers, P. A. 1999. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum. Reprod. 14:2080–2088. PubMedCrossRefGoogle Scholar
  47. Gath, D., Osborn, M., and Bungay, G. 1987. Psychiatric disorder and gynaecological symptoms in middle-aged women: a community survey. Br. Med. J. 294:213–218. CrossRefGoogle Scholar
  48. Gordon, J. D., Shifren, J. L., Foulk, R. A., Taylor, R. N., and Jaffe, R. B. 1995. Angiogenesis in the female reproductive tract. Obstet. Gynecol. Surv. 50:688–696. PubMedCrossRefGoogle Scholar
  49. Hallberg, L., Hogdahl, A M., Nilsson, L., and Rybo, G. 1966. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet. Gynecol. Scand. 45:320–351. PubMedCrossRefGoogle Scholar
  50. Hampton, A. L., and Salamonsen, L. 1994. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J. Endocrinol. 141:R1–R3.PubMedCrossRefGoogle Scholar
  51. Haynes, P. J., Hodgson, H., Anderson, A. B. M., and Turnbull, A. C. 1977. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br. J. Obstet. Gynaecol. 84:763–768.PubMedCrossRefGoogle Scholar
  52. Henzl, M. R., Smith, R. E., Boost, G., and Tyler, E. T. 1972. Lysosomal concept of menstrual bleeding in humans. J. Clin. Endocrinol. Metab. 34:860–875.PubMedCrossRefGoogle Scholar
  53. Hickey, M., Carati, C., Manconi, F., Gannon, B. J., Dwarte, D., and Fraser, I. S. 2000a. The measurement of endometrial perfusion in Norplant users: a pilot study. Hum. Reprod. 15:1086–1091.CrossRefGoogle Scholar
  54. Hickey, M., Fraser, I. S., Dwarte, D., and Graham, S. 1996. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study. Hum. Reprod. I1(suppl 2):35–44.CrossRefGoogle Scholar
  55. Hickey, M., Higham, J., Sullivan, M., et al. 2000b. Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of MMP-9. Fertil. Steril. in press.Google Scholar
  56. Hickey, M., Simbar, M., Markham, R., Young, L., Manconi, F., Russell, P., and Fraser, I. S. 1999b. Changes in vascular basement membrane in the endometrium of Norplant users. Hum. Reprod. 14:716–721.CrossRefGoogle Scholar
  57. Hickey, M., Simbar, M., Young, L., Markham, R., Russell, P., and Fraser, I. S. 1999a. A longitudinal study of changes in endometrial microvascular density in Norplant implant users. Contraception 59:123–129.CrossRefGoogle Scholar
  58. Hirschi, K. K., and D’Amore, P. A. 1996. Pericytes in the microvasculature. Cardiovasc. Res. 32:687–698.PubMedGoogle Scholar
  59. Hoffman, M. K., Meilstrup, J. W., Shackelford, D. P., and Kaminski, P. E 1997. Arteriovenous malformations of the uterus: an uncommon cause of vaginal bleeding. Obstet. Gynecol. Surv. 52:736–740.PubMedCrossRefGoogle Scholar
  60. Hourihan, H. M., Sheppard, B. L., and Bonnar, J. 1986. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels. Contraception 38:603–612.CrossRefGoogle Scholar
  61. Hourihan, H. M., Sheppard, B. L., and Bonnar, J. 1989. The morphologic characteristics of menstrual haemostasis in patients with unexplained menorrhagia. Int. J. Gynecol. Pathol. 8:221–229.PubMedCrossRefGoogle Scholar
  62. Huang, M. W., Muradali, D., Thurston, W. A., Burns, P. N., and Wilson, S. R. 1998. Uterine arteriovenous malformations: Gray-scale and Doppler US features with MR imaging correlation. Radiology 206:115–123.PubMedGoogle Scholar
  63. Iruela-Arispe, M. L., Rodriguez-Manzaneque, J. C., and Abu-Jawdeh, G. 1999. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation 6:127–140.PubMedGoogle Scholar
  64. Kamat, B. R., and Isaacson, P. G. 1987. The immunocytochemical distribution of leukocyte populations in human endometrium. Am. J. Pathol. 127:66–73.PubMedGoogle Scholar
  65. Kasonde, J. M., and Bonnar, J. 1976. Plasminogen activators in the endometrium of women using intrauterine contraceptive devices. Br. J. Obstet. Gynaecol. 83:315–319.PubMedCrossRefGoogle Scholar
  66. Koh, S. C. L., Wong, P. C., Yuen, R., Chua, S. E., Ng, B. L., and Ratnam, S. S. 1992. Concentration of plasminogen activators and inhibitors in human endometrium at different stages of the menstrual cycle. J. Reprod. FertiL 96:407–413.PubMedCrossRefGoogle Scholar
  67. Lakhani, K. P., Marsh, M. S., Purcell, W., and Hardiman, P. 1998. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid. Ultrasound Obstet. Gynecol. 11:283–285.PubMedCrossRefGoogle Scholar
  68. Landgren, B. M., Johannisson, E., Masirono, B., and Diczfalusy, E. 1982. Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order. Contraception 26:567–585.PubMedCrossRefGoogle Scholar
  69. Larson, R. S., and Springer, T. A. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114:181–217.PubMedCrossRefGoogle Scholar
  70. Lau, T. M., Affandi, B., and Rogers P. A. W. 1999. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol. Hum. Reprod. 5:557–563.CrossRefGoogle Scholar
  71. Lockwood, C. J., Krikun, G., Hausknecht, V., Wang, E. Y., and Schatz, F. 1997. Decidual cell regulation of hemostasis during implantation and menstruation. Ann. NY Acad. Sci. 828:188–193.PubMedCrossRefGoogle Scholar
  72. Lumsden, M. A. 1998. Clinical presentation of uterine fibroids. Baillieres Clin. Obstet. Gynaecol. 12:177–195.PubMedCrossRefGoogle Scholar
  73. Manolitsas, T., Hurley, V., and Gilford, E. 1994. Uterine arteriovenous malformation-a rare cause of uterine haemorrhage. Aust. N. Z. J. Obstet. Gynaecol. 34:197–199.PubMedCrossRefGoogle Scholar
  74. Maqueo, M. 1980. Vascular and perivascular changes in the endometrium of women using steroidal contraceptives. In: Diczfalusy, E., Fraser, I. S., and Webb, F. T. G., eds. Endometrial Bleeding and Steroidal Contraception. Pitman Press, Bath, pp. 138–152.Google Scholar
  75. Marbaix, E., Kokorine, I., Henriet, P., Donnez, J., Courtoy, P. J., and Eeckhout, Y. 1995. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem. J. 305:1027–1030.Google Scholar
  76. Markee, J. E. 1940. Menstruation in intraoccular endometrial transplants in the rhesus monkey. Contrib. Embryol. 177:220–306.Google Scholar
  77. Markee, J. E. 1948. Morphological basis for menstrual bleeding: relation of regression to the initiation of bleeding. Bull. NY Acad. Med. 24:253–268.Google Scholar
  78. Markee, J. E. 1950. The relation of blood flow to endometrial growth and the inception of menstruation. In: Engle, E. T., ed. Menstruation and Its Disorders. Charles C. Thomas, Springfield, IL, pp. 165–185.Google Scholar
  79. Marleschki, V. 1968. Hysteroskopische Feststellung der spontanen Perfusionsschwankugen am menschlichen Endometrium. Zentralbl. Gynakol. 90:1094–1097.PubMedGoogle Scholar
  80. Marsh, M. M., Findlay, J. K., and Salamonsen, L. A. 1996. Endothelin and menstruation. Hum. Reprod. 11(suppl 2):83–89.PubMedCrossRefGoogle Scholar
  81. Matsumoto, Y., Iwasaka, T., Yamasaki, F., and Sugimori, H. 1999. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet. Gynecol. 94:71–77.PubMedCrossRefGoogle Scholar
  82. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Möller, N. P., Risau, W., and Ullrich, A. 1993. High affinity VEGF binding and developmental expression suggests Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835–846.PubMedCrossRefGoogle Scholar
  83. Neufield, G., Tessler, G., and Gitay, G. H. 1994. Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res. 5:89–97.Google Scholar
  84. Odlind, V., and Fraser, I. S. 1990. Contraception and menstrual bleeding disturbances: a clinical overview. In: d’Arcangues, C., Fraser, I. S., Newton, J. R., and Odlind, V., eds. Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, pp. 5–31.Google Scholar
  85. Ota, H., Igarashi, S., and Tanaka, T. 1998. Morphometric evaluation of stromal vascularization in the endometrium of adenomyosis. Hum. Reprod. 13:715–719.PubMedCrossRefGoogle Scholar
  86. Padwick, M. L., Pryse-Davies, M. I., and Whitehead, M. 1986. A simple method for determining the optimal dose of progestin in women receiving estrogens. N. Engl. J. Med. 315:930–933.PubMedCrossRefGoogle Scholar
  87. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. 1991. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181:902–906.PubMedCrossRefGoogle Scholar
  88. Perrot-Aplanat, M., Groyer-Pickard, M. T., Garcia, E., Lorenzo, F., and Milgrom, E. 1988. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 123:1511–1519.CrossRefGoogle Scholar
  89. Purcell, T. L., Given, R., Chwalisz, K., and Garfield, R. E. 1999. Nitric oxide synthetase distribution during implantation in the mouse. Mol. Hum. Reprod. 5:467–475.PubMedCrossRefGoogle Scholar
  90. Rai, R., and Regan, L. 1998. Antiphospholipid syndrome and pregnancy loss. Hosp. Med 59:637–639.Google Scholar
  91. Ramsey, E. M. 1982. Vascular anatomy. In: Wynn, R. M., ed. Biology of the Uterus, 2nd ed. Plenum Press, New York, pp. 59–76.Google Scholar
  92. Rand, J. H. 1998. Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms. Am. J. Med. Sci. 316:142–151.PubMedCrossRefGoogle Scholar
  93. Rand, J. H., Wu, X. X., Andree, H. A., Lockwood, C. J., Guller, S., Scher, J., and Harpel, P. C. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N. Engl. J. Med. 337:154–160.PubMedCrossRefGoogle Scholar
  94. Ravina, J. A., Herbreteau, D., Ciraru-Vigneron, N., Bouret, J. M., Houdart, E., Aymard, A., and Merland, J. J. 1995. Arterial embolisation to treat uterine myomata. Lancet 346:671–672.PubMedCrossRefGoogle Scholar
  95. Rees, M. C. P., Canete-Soler, R. Lopez-Bernal, A., and Turnbull, A. C. 1988. Effect of fenamates on prostaglandin E receptor binding. Lancet 2:541–542.Google Scholar
  96. Rees, M. C. P., Cederholm-Williams, S. A., and Turnbull, A. C. 1985. Coagulation factors and fibrinolytic proteins in menstrual fluid collected from normal and menorrhagic women. Br. J. Obstet. Gynaecol. 92:1164–1168.PubMedCrossRefGoogle Scholar
  97. Rees, M. C. P., Demers L. M., Anderson, A. B. M., and Turnbull, A. C. 1984a. A functional study of platelets in menstrual fluid. Br. J. Obstet. Gynaecol. 91:667–672.CrossRefGoogle Scholar
  98. Rees, M. C. P., Dunnhill, M. S., Anderson, A. B., and Turnbull, A. C. 1984b. Quantitative uterine histology during the menstrual cycle related to measured blood loss. Br. J. Obstet. Gynaecol. 91:662–666.CrossRefGoogle Scholar
  99. Rein, M. S., Barbieri, R. L., and Friedman, A. J. 1995. Progesterone: a critical role in the pathogenesis of uterine myomas. Am. J. Obstet. Gynecol. 172:14–18.PubMedCrossRefGoogle Scholar
  100. Rogers, P. A. W. 1995. Current studies on human implantation. Reprod. Fertil. Del,. 7:1395–1399.CrossRefGoogle Scholar
  101. Rogers, P. A. W., Au, C. L., and Affandi, B. 1993. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum. Reprod. 8:1396–1404.PubMedGoogle Scholar
  102. Rogers, P. A. W, Lederman, F., and Taylor, N. 1998. Endometrial microvascular growth in normal and dysfunctional states. Hum. Reprod. Update 4:503–508.PubMedCrossRefGoogle Scholar
  103. Rogers, P. A. W, Salamonsen, L. A., Runic, R., Schata, F., and Krey, L. 1997. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception. J. Clin. Endocrinol. Metab. 72:1983–1988.Google Scholar
  104. Runic, R., Schatz, F., Krey, L., Demopoulos, R., Thung, S., Wan, L., and Lockwood, C. J. 1997. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception. J. Clin. Endocrinol. Metab. 82:1983–1988.PubMedCrossRefGoogle Scholar
  105. Rybo, G., Leman, J., and Tibblin, E. 1985. Epidemiology of menstrual blood loss. In: Baird, D. T., and Michie, E. A., eds. Mechanism of Menstrual Bleeding. Raven Press, New York, pp. 181–194.Google Scholar
  106. Salamonsen, L. A., Marsh, M. M., and Findlay, J. K. 1999. Endometrial endothelin: regulator of uterine bleeding and endometrial repair. Clin. Exp. Pharmacol. Physiol. 26:154157.Google Scholar
  107. Salamonsen, L. A., and Woolley, D. E. 1996. Matrix metalloproteinases in normal menstruation. Hum. Reprod. 11(suppl 2):124–133.PubMedCrossRefGoogle Scholar
  108. Salvatore, C. A. 1968. Arteriole alternation in normal and hyperplastic endometrium. Am. J. Obstet. Gynecol. 102:493–500.PubMedGoogle Scholar
  109. Sapozhnikov, A. G. 1987. Structure of the blood microcirculatory bed in intramural uterine myomas. Vopr. Onkol. 33:43–48.PubMedGoogle Scholar
  110. Sarfati, R., and Brux, J. 1973. Vascular fragility of the endometrium under oestrogenprogestin treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. 2:87–94.Google Scholar
  111. Sheppard, B. L. 1990. Coagulation and electron microscopy studies in menorrhagia. In: Shaw, R. W., ed. Advances in Reproductive Endocrinology, vol. 2. Parthenon Press, Carnforth, Lancs, UK. pp. 25–42.Google Scholar
  112. Sixma, J., Christiaens G. C. M. L., and Haspels, A. A. 1980. The sequence of haemostatic events in the endometrium during normal menstruation. In: Diczfalusy, E., Fraser, I. S., and Webb, F. T. G., eds. Endometrial Bleeding and Steroidal Contraception. Pitman Press, Bath, England, pp. 86–96.Google Scholar
  113. Skinner, J. L., Riley, S. C., Gebbie, A. E., Glasier, A. F., and Critchley, H. O. 1999. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum. Reprod. 14:793–799.PubMedCrossRefGoogle Scholar
  114. Skopichev, V. G., and Savitskii, G. A. 1992. Changes in the human uterine vascular bed in myoma. Arkh. Patol 54:27–30.PubMedGoogle Scholar
  115. Song, J. Y., Russell, P., Markham, R., Manconi, F., and Fraser, I. S. 1996. Effects of high dose progestogens on white cells and necrosis in human endometrium. Hum. Reprod. 11:1713–1718.PubMedCrossRefGoogle Scholar
  116. Sosic, A., Skupski, D. W, Streltzoff, J., Yun, H., and Chervenak, F. A. 1996. Vascularity of uterine myomas: assessment by color and pulsed Doppler ultrasound. Int. J. Gynaecol. Obstet. 54:245–250.PubMedCrossRefGoogle Scholar
  117. Smith, S. K. 1990. The physiology of menstruation. In: d’Arcangues, C., Fraser, I. S., Newton, J. R., and Odlind, V., eds. Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, pp. 33–41.Google Scholar
  118. Smith, S. K. 1998. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum. Reprod. Update 4:509–519.PubMedCrossRefGoogle Scholar
  119. Smith, S. K., Abel, M. H., Kelly, R. W., and Baird, D. T. 1981. A role for prostacyclin (PGI2) in excessive menstrual bleeding. Lancet 1(8219):522–524.PubMedCrossRefGoogle Scholar
  120. Smith, S. K., Abel, M. H., Kelly, R. W, and Baird, D. T. 1982. The synthesis of prostaglandins from persistent proliferative endometrium. J. Clin. Endocrinol. Metab. 55:284–289.PubMedCrossRefGoogle Scholar
  121. Stewart, E. A., and Nowak, R. A. 1996. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum. Reprod. Update 2:295–306.PubMedCrossRefGoogle Scholar
  122. Subakir, S. B., Hadisaputra, W, Handoyo, A. E., and Affandi, B. 1996. Endometrial angiogenic response in Norplant users. Hum. Reprod. 11(suppl 2):51–55.PubMedCrossRefGoogle Scholar
  123. Tabibzadeh, S. 1991. Human endometrium: an active site of cytokine production and action. Endocr. Rev. 12:272–290.PubMedCrossRefGoogle Scholar
  124. Tabibzadeh S. 1996. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol. Hum. Reprod. 2:770792.Google Scholar
  125. Tabibzadeh, S., and Satyaswaroop, P. G. 1989. Sex steroid receptors in lymphoid cells of human endometrium. Am. J. Clin. PathoL 91:656–663.PubMedGoogle Scholar
  126. Tabibzadeh, S., and Sun, X. Z. 1992. Cytokine expression in human endometrium throughout the menstrual cycle. Hum. Reprod. 7:1214–1221.PubMedGoogle Scholar
  127. Treloar, A. E., Boynton, R. E., Behn, B. G., and Brown, B. W. 1970. Variation of the human menstrual cycle throughout reproductive life. Int. J. Fertil. 12:77–113.Google Scholar
  128. Van Herendael, B. J., Stevens, M. J., Flakiewicz-Kula, A., and Hansch, C. 1987. Dating of the endometrium by microhysteroscopy. Gynecol. Obstet. Invest. 24:114–118.PubMedCrossRefGoogle Scholar
  129. Vincent, A. J., Malakooti, N., Zhang J., Rogers, P. A., Affandi, B., and Salamonsen, L. A. 1999. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix-metalloproteinase-9 (gelatinase B). Hum. Reprod. 14:807–814.PubMedCrossRefGoogle Scholar
  130. Vollman, R. F. 1977. The Menstrual Cycle. W. B. Saunders, Philadelphia.Google Scholar
  131. Wang, I. Y. S., and Fraser, I. S. 1990. Lysosomes: an important mediator in the human reproductive tract. Obstet. Gynecol. Surv. 45:18–33.PubMedCrossRefGoogle Scholar
  132. Wang, I. Y., Fraser, I. S., Barsamian, S. P., Manconi, F., Street, D. J., Cornillie, F. J., and Russell, P. 2000. Endometrial lysosomal enzyme activity in ovulatory dysfunctional bleeding, IUCD users and in postpartum women. Mol. Hum. Reprod. 6:101–106.Google Scholar
  133. Yang, J. H., Wu, M. Y., Chen, C. D., Jiang, M. C., Ho, H. N., and Yang, Y. S. 1999. Association of endometrial blood flow as determined by a modified colour Doppler technique with subsequent outcome of in-vitro fertilisation. Hum. Reprod. 14:1606–1610.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Martha Hickey
  • Ian S. Fraser

There are no affiliations available

Personalised recommendations